BACKGROUND: Wnt5a, p-JNK and p-paxillin proteins have been shown to be associated with the development of several types of cancer. Here we studied the role of Wnt5a, p-JNK and p-paxillin protein expressions and functions in the further development of pancreatic adenocarcinoma. METHODS: Fresh tissue samples from adjacent and malignant portions were obtained after operation from 58 patients with pancreatic adenocarcinoma. Wnt5a, p-JNK1, JNK1, paxillin and p-paxillin were detected with immunohistochemical staining. RESULTS: The expressions of Wnt5a, p-JNK1 and p-paxillin were higher in malignant tissues than in adjacent portions (p < 0.01), where JNK1 and paxillin were absent (p > 0.05). The expression levels of Wnt5a, p-JNK1 and p-paxillin in tumor tissues were correlated with each other (r = 0.564, 0.586 and 0.737, respectively). The expression of Wnt5a in tumor tissue could independently predict the occurrence of lymph node involvement [odds ratio (OR) 8.19, 95 % confidence interval (CI) 2.47-27.19]. The expression of p-JNK1 in tumor tissue was an independent predictor of peritoneal metastasis (OR 4.01, 95 % CI 1.32-12.17). CONCLUSION: Wnt5a/JNK signaling might be activated in pancreatic cancer. Wnt5a is the specific predictor for lymph node involvement.
BACKGROUND:Wnt5a, p-JNK and p-paxillin proteins have been shown to be associated with the development of several types of cancer. Here we studied the role of Wnt5a, p-JNK and p-paxillin protein expressions and functions in the further development of pancreatic adenocarcinoma. METHODS: Fresh tissue samples from adjacent and malignant portions were obtained after operation from 58 patients with pancreatic adenocarcinoma. Wnt5a, p-JNK1, JNK1, paxillin and p-paxillin were detected with immunohistochemical staining. RESULTS: The expressions of Wnt5a, p-JNK1 and p-paxillin were higher in malignant tissues than in adjacent portions (p < 0.01), where JNK1 and paxillin were absent (p > 0.05). The expression levels of Wnt5a, p-JNK1 and p-paxillin in tumor tissues were correlated with each other (r = 0.564, 0.586 and 0.737, respectively). The expression of Wnt5a in tumor tissue could independently predict the occurrence of lymph node involvement [odds ratio (OR) 8.19, 95 % confidence interval (CI) 2.47-27.19]. The expression of p-JNK1 in tumor tissue was an independent predictor of peritoneal metastasis (OR 4.01, 95 % CI 1.32-12.17). CONCLUSION:Wnt5a/JNK signaling might be activated in pancreatic cancer. Wnt5a is the specific predictor for lymph node involvement.
Authors: Jose Roman-Gomez; Antonio Jimenez-Velasco; Lucia Cordeu; Amaia Vilas-Zornoza; Edurne San Jose-Eneriz; Leire Garate; Juan A Castillejo; Vanesa Martin; Felipe Prosper; Anabel Heiniger; Antonio Torres; Xabier Agirre Journal: Eur J Cancer Date: 2007-12 Impact factor: 9.162
Authors: Yick-Pang Ching; Veronica Y L Leong; Man-Fong Lee; Hai-Tao Xu; Dong-Yan Jin; Irene Oi-Lin Ng Journal: Cancer Res Date: 2007-04-15 Impact factor: 12.701
Authors: Michael W Susman; Edith P Karuna; Ryan C Kunz; Taranjit S Gujral; Andrea V Cantú; Shannon S Choi; Brigette Y Jong; Kyoko Okada; Michael K Scales; Jennie Hum; Linda S Hu; Marc W Kirschner; Ryuichi Nishinakamura; Soichiro Yamada; Diana J Laird; Li-En Jao; Steven P Gygi; Michael E Greenberg; Hsin-Yi Henry Ho Journal: Elife Date: 2017-09-08 Impact factor: 8.140
Authors: Marwa S Asem; Steven Buechler; Rebecca Burkhalter Wates; Daniel L Miller; M Sharon Stack Journal: Cancers (Basel) Date: 2016-08-26 Impact factor: 6.639